4.7 Article

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

Journal

CLINICAL INFECTIOUS DISEASES
Volume 53, Issue 7, Pages E25-E76

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cir531

Keywords

-

Funding

  1. IDSA
  2. Johnson & Johnson Pharmaceuticals
  3. Cubist
  4. Merck
  5. Sanofi Pasteur
  6. Astellas
  7. National Institutes of Health
  8. Robert Wood Johnson Foundation
  9. Wyeth Pharmaceuticals
  10. GlaxoSmithKline

Ask authors/readers for more resources

Evidenced-based guidelines for management of infants and children with community-acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and investigators representing community pediatrics, public health, and the pediatric specialties of critical care, emergency medicine, hospital medicine, infectious diseases, pulmonology, and surgery. These guidelines are intended for use by primary care and subspecialty providers responsible for the management of otherwise healthy infants and children with CAP in both outpatient and inpatient settings. Site-of-care management, diagnosis, antimicrobial and adjunctive surgical therapy, and prevention are discussed. Areas that warrant future investigations are also highlighted.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available